tiprankstipranks
Buy These Olympic Stocks, Say Wall Street Analysts
PremiumMarket NewsBuy These Olympic Stocks, Say Wall Street Analysts
13d ago
Kymera Therapeutics jumps 10% to $35.09 after expanding phase 2 trials
PremiumThe Fly
Kymera Therapeutics jumps 10% to $35.09 after expanding phase 2 trials
14d ago
Kymera expands HS and AD Phase 2  trials following review
PremiumThe Fly
Kymera expands HS and AD Phase 2 trials following review
14d ago
Sanofi Advances Polio Eradication with Biovac Partnership
PremiumCompany AnnouncementsSanofi Advances Polio Eradication with Biovac Partnership
20d ago
Sanofi price target raised to EUR 120 from EUR 115 at Jefferies
PremiumThe Fly
Sanofi price target raised to EUR 120 from EUR 115 at Jefferies
20d ago
Sanofi says frexalimab reduced biomarker of nerve cell damage in Phase 2 data
PremiumThe Fly
Sanofi says frexalimab reduced biomarker of nerve cell damage in Phase 2 data
21d ago
Sanofi seeking initial bids for $20B consumer health unit, Bloomberg reports
PremiumThe FlySanofi seeking initial bids for $20B consumer health unit, Bloomberg reports
27d ago
Sanofi a winner from ‘highly impressive’ Alnylam data, says Citi
PremiumThe Fly
Sanofi a winner from ‘highly impressive’ Alnylam data, says Citi
28d ago
Sanofi, Biovac spearhead polio vaccine manufacturing capabilities in Africa
PremiumThe Fly
Sanofi, Biovac spearhead polio vaccine manufacturing capabilities in Africa
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100